25 XP   0   0   10

KPC Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Kpc together

PenkeI guess you are interested in KPC Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of KPC Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about KPC Pharmaceuticals Inc

I send you an email if I find something interesting about KPC Pharmaceuticals Inc.

Quick analysis of Kpc (30 sec.)










What can you expect buying and holding a share of Kpc? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.23
Expected worth in 1 year
¥7.67
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥0.63
Return On Investment
2.9%

For what price can you sell your share?

Current Price per Share
¥21.60
Expected price per share
¥17.66 - ¥22.50
How sure are you?
50%

1. Valuation of Kpc (5 min.)




Live pricePrice per Share (EOD)

¥21.60

Intrinsic Value Per Share

¥7.02 - ¥14.18

Total Value Per Share

¥14.24 - ¥21.40

2. Growth of Kpc (5 min.)




Is Kpc growing?

Current yearPrevious yearGrowGrow %
How rich?$755.7m$700.3m$37.9m5.1%

How much money is Kpc making?

Current yearPrevious yearGrowGrow %
Making money$15.3m$13.2m$2.1m13.8%
Net Profit Margin5.9%4.7%--

How much money comes from the company's main activities?

3. Financial Health of Kpc (5 min.)




What can you expect buying and holding a share of Kpc? (5 min.)

Welcome investor! Kpc's management wants to use your money to grow the business. In return you get a share of Kpc.

What can you expect buying and holding a share of Kpc?

First you should know what it really means to hold a share of Kpc. And how you can make/lose money.

Speculation

The Price per Share of Kpc is ¥21.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kpc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kpc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.23. Based on the TTM, the Book Value Change Per Share is ¥0.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kpc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.0%0.020.1%0.020.1%0.020.1%0.020.1%
Usd Book Value Change Per Share0.010.1%0.020.1%0.010.0%0.010.1%0.020.1%
Usd Dividend Per Share0.000.0%0.010.0%0.010.0%0.010.0%0.010.1%
Usd Total Gains Per Share0.010.1%0.020.1%0.020.1%0.020.1%0.030.1%
Usd Price Per Share2.88-2.81-1.72-1.73-2.18-
Price to Earnings Ratio67.37-40.55-19.23-22.25-32.66-
Price-to-Total Gains Ratio213.92--114.41-223.62-59.37-70.54-
Price to Book Ratio2.89-2.89-1.86-1.97-3.72-
Price-to-Total Gains Ratio213.92--114.41-223.62-59.37-70.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.9808
Number of shares335
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.020.02
Gains per Quarter (335 shares)7.337.64
Gains per Year (335 shares)29.3430.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
192019112021
2184148214052
3276177326083
435821064380114
54410213553100145
65312316464119176
76214319374139207
87116422285159238
98018425196179269
1089205280106199300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%86.00.02.097.7%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%16.04.00.080.0%32.08.00.080.0%70.018.00.079.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%68.00.020.077.3%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%37.03.00.092.5%80.08.00.090.9%

Fundamentals of Kpc

About KPC Pharmaceuticals Inc

KPC Pharmaceuticals, Inc, a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-17 07:50:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of KPC Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kpc earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Kpc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.8% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of KPC Pharmaceuticals Inc:

  • The MRQ is 2.8%. The company is making a profit. +1
  • The TTM is 5.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM5.9%-3.1%
TTM5.9%YOY4.7%+1.2%
TTM5.9%5Y5.7%+0.2%
5Y5.7%10Y6.3%-0.6%
1.1.2. Return on Assets

Shows how efficient Kpc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kpc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Assets means that Kpc generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of KPC Pharmaceuticals Inc:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.6%TTM1.2%-0.6%
TTM1.2%YOY1.1%+0.1%
TTM1.2%5Y1.4%-0.2%
5Y1.4%10Y1.7%-0.3%
1.1.3. Return on Equity

Shows how efficient Kpc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kpc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.1% Return on Equity means Kpc generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of KPC Pharmaceuticals Inc:

  • The MRQ is 1.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM2.1%-1.0%
TTM2.1%YOY2.0%+0.2%
TTM2.1%5Y2.5%-0.3%
5Y2.5%10Y2.8%-0.4%

1.2. Operating Efficiency of KPC Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kpc is operating .

  • Measures how much profit Kpc makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kpc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of KPC Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.6%-3.6%
TTM3.6%YOY6.5%-3.0%
TTM3.6%5Y5.7%-2.1%
5Y5.7%10Y3.2%+2.5%
1.2.2. Operating Ratio

Measures how efficient Kpc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.49 means that the operating costs are ¥1.49 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of KPC Pharmaceuticals Inc:

  • The MRQ is 1.488. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.463. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.488TTM1.463+0.025
TTM1.463YOY1.506-0.043
TTM1.4635Y1.484-0.021
5Y1.48410Y1.110+0.374

1.3. Liquidity of KPC Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kpc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.93 means the company has ¥1.93 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of KPC Pharmaceuticals Inc:

  • The MRQ is 1.929. The company is able to pay all its short-term debts. +1
  • The TTM is 1.896. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.929TTM1.896+0.034
TTM1.896YOY1.779+0.116
TTM1.8965Y1.800+0.095
5Y1.80010Y1.027+0.773
1.3.2. Quick Ratio

Measures if Kpc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kpc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.87 means the company can pay off ¥0.87 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of KPC Pharmaceuticals Inc:

  • The MRQ is 0.866. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.890. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.866TTM0.890-0.024
TTM0.890YOY0.852+0.038
TTM0.8905Y0.812+0.078
5Y0.81210Y0.781+0.031

1.4. Solvency of KPC Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kpc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kpc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.43 means that Kpc assets are financed with 42.7% credit (debt) and the remaining percentage (100% - 42.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of KPC Pharmaceuticals Inc:

  • The MRQ is 0.427. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.424. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.427TTM0.424+0.004
TTM0.424YOY0.445-0.022
TTM0.4245Y0.429-0.005
5Y0.42910Y0.393+0.036
1.4.2. Debt to Equity Ratio

Measures if Kpc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kpc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 77.2% means that company has ¥0.77 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of KPC Pharmaceuticals Inc:

  • The MRQ is 0.772. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.758. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.772TTM0.758+0.014
TTM0.758YOY0.828-0.070
TTM0.7585Y0.777-0.019
5Y0.77710Y0.681+0.095

2. Market Valuation of KPC Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Kpc generates.

  • Above 15 is considered overpriced but always compare Kpc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 67.37 means the investor is paying ¥67.37 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of KPC Pharmaceuticals Inc:

  • The EOD is 69.762. Based on the earnings, the company is expensive. -2
  • The MRQ is 67.372. Based on the earnings, the company is expensive. -2
  • The TTM is 40.554. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD69.762MRQ67.372+2.390
MRQ67.372TTM40.554+26.818
TTM40.554YOY19.231+21.323
TTM40.5545Y22.254+18.300
5Y22.25410Y32.656-10.402
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of KPC Pharmaceuticals Inc:

  • The EOD is 10.996. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.619. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.639. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.996MRQ10.619+0.377
MRQ10.619TTM8.639+1.981
TTM8.639YOY14.247-5.608
TTM8.6395Y15.097-6.458
5Y15.09710Y-16.562+31.658
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kpc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of KPC Pharmaceuticals Inc:

  • The EOD is 2.990. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.887. Based on the equity, the company is underpriced. +1
  • The TTM is 2.888. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.990MRQ2.887+0.102
MRQ2.887TTM2.8880.000
TTM2.888YOY1.860+1.028
TTM2.8885Y1.971+0.916
5Y1.97110Y3.723-1.751
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of KPC Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0890.111-20%0.067+33%0.108-18%0.119-25%
Book Value Per Share--7.2257.058+2%6.693+8%6.287+15%5.196+39%
Current Ratio--1.9291.896+2%1.779+8%1.800+7%1.027+88%
Debt To Asset Ratio--0.4270.424+1%0.445-4%0.4290%0.393+9%
Debt To Equity Ratio--0.7720.758+2%0.828-7%0.777-1%0.681+13%
Dividend Per Share--0.0090.048-82%0.077-89%0.058-85%0.082-89%
Eps--0.0770.147-47%0.166-53%0.155-50%0.136-43%
Free Cash Flow Per Share--0.4910.096+412%0.050+879%0.052+841%0.076+547%
Free Cash Flow To Equity Per Share--0.491-0.035+107%-0.021+104%-0.016+103%0.081+508%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--14.178--------
Intrinsic Value_10Y_min--7.016--------
Intrinsic Value_1Y_max--0.466--------
Intrinsic Value_1Y_min--0.289--------
Intrinsic Value_3Y_max--2.127--------
Intrinsic Value_3Y_min--1.231--------
Intrinsic Value_5Y_max--4.666--------
Intrinsic Value_5Y_min--2.566--------
Market Cap16353662054.400+3%15811608173.34015441652894.530+2%9440284324.050+67%9538301837.142+66%11980976604.548+32%
Net Profit Margin--0.0280.059-52%0.047-40%0.057-51%0.063-55%
Operating Margin---0.036-100%0.065-100%0.057-100%0.032-100%
Operating Ratio--1.4881.463+2%1.506-1%1.484+0%1.110+34%
Pb Ratio2.990+3%2.8872.8880%1.860+55%1.971+46%3.723-22%
Pe Ratio69.762+3%67.37240.554+66%19.231+250%22.254+203%32.656+106%
Price Per Share21.600+3%20.86020.370+2%12.450+68%12.531+66%15.782+32%
Price To Free Cash Flow Ratio10.996+3%10.6198.639+23%14.247-25%15.097-30%-16.562+256%
Price To Total Gains Ratio221.514+3%213.925-114.414+153%223.618-4%59.370+260%70.545+203%
Quick Ratio--0.8660.890-3%0.852+2%0.812+7%0.781+11%
Return On Assets--0.0060.012-49%0.011-42%0.014-55%0.017-63%
Return On Equity--0.0110.021-48%0.020-43%0.025-55%0.028-61%
Total Gains Per Share--0.0980.159-39%0.144-32%0.165-41%0.201-51%
Usd Book Value--755766577.056738321701.147+2%700399383.311+8%660351557.167+14%545406196.122+39%
Usd Book Value Change Per Share--0.0120.015-20%0.009+33%0.015-18%0.016-25%
Usd Book Value Per Share--0.9970.974+2%0.924+8%0.868+15%0.717+39%
Usd Dividend Per Share--0.0010.007-82%0.011-89%0.008-85%0.011-89%
Usd Eps--0.0110.020-47%0.023-53%0.021-50%0.019-43%
Usd Free Cash Flow--51368187.66110025740.190+412%5249134.152+879%5461806.996+840%7151048.842+618%
Usd Free Cash Flow Per Share--0.0680.013+412%0.007+879%0.007+841%0.010+547%
Usd Free Cash Flow To Equity Per Share--0.068-0.005+107%-0.003+104%-0.002+103%0.011+508%
Usd Market Cap2256805363.507+3%2182001927.9212130948099.445+2%1302759236.719+67%1316285653.526+66%1653374771.428+32%
Usd Price Per Share2.981+3%2.8792.811+2%1.718+68%1.729+66%2.178+32%
Usd Profit--8096785.04715341458.662-47%13219833.871-39%15502207.939-48%13893629.459-42%
Usd Revenue--288731532.940265757683.361+9%285731189.248+1%276522795.571+4%231376958.682+25%
Usd Total Gains Per Share--0.0130.022-39%0.020-32%0.023-41%0.028-51%
 EOD+4 -4MRQTTM+15 -20YOY+20 -155Y+18 -1710Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of KPC Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1569.762
Price to Book Ratio (EOD)Between0-12.990
Net Profit Margin (MRQ)Greater than00.028
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.866
Current Ratio (MRQ)Greater than11.929
Debt to Asset Ratio (MRQ)Less than10.427
Debt to Equity Ratio (MRQ)Less than10.772
Return on Equity (MRQ)Greater than0.150.011
Return on Assets (MRQ)Greater than0.050.006
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of KPC Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.500
Ma 20Greater thanMa 5021.412
Ma 50Greater thanMa 10020.631
Ma 100Greater thanMa 20020.365
OpenGreater thanClose21.600
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets9,565,383
Total Liabilities4,088,814
Total Stockholder Equity5,297,444
 As reported
Total Liabilities 4,088,814
Total Stockholder Equity+ 5,297,444
Total Assets = 9,565,383

Assets

Total Assets9,565,383
Total Current Assets7,031,045
Long-term Assets2,534,339
Total Current Assets
Cash And Cash Equivalents 1,493,010
Short-term Investments 603,795
Net Receivables 2,550,998
Inventory 1,688,247
Other Current Assets 78,916
Total Current Assets  (as reported)7,031,045
Total Current Assets  (calculated)6,414,967
+/- 616,078
Long-term Assets
Property Plant Equipment 1,248,690
Goodwill 91,727
Intangible Assets 525,493
Long-term Assets Other 41,441
Long-term Assets  (as reported)2,534,339
Long-term Assets  (calculated)1,907,351
+/- 626,987

Liabilities & Shareholders' Equity

Total Current Liabilities3,644,259
Long-term Liabilities444,555
Total Stockholder Equity5,297,444
Total Current Liabilities
Short Long Term Debt 725,487
Accounts payable 932,691
Other Current Liabilities 54,554
Total Current Liabilities  (as reported)3,644,259
Total Current Liabilities  (calculated)1,712,732
+/- 1,931,527
Long-term Liabilities
Long term Debt 107,561
Capital Lease Obligations Min Short Term Debt44,238
Long-term Liabilities Other 74,854
Long-term Liabilities  (as reported)444,555
Long-term Liabilities  (calculated)226,653
+/- 217,902
Total Stockholder Equity
Retained Earnings 3,017,324
Total Stockholder Equity (as reported)5,297,444
Total Stockholder Equity (calculated)3,017,324
+/- 2,280,120
Other
Capital Stock757,987
Common Stock Shares Outstanding 757,987
Net Invested Capital 6,130,493
Net Working Capital 3,386,786
Property Plant and Equipment Gross 1,248,690



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-31
> Total Assets 
798,796
755,246
763,983
778,291
769,950
780,336
763,285
835,482
852,859
951,483
946,711
970,314
984,933
1,081,447
1,171,947
1,032,461
1,127,721
1,376,085
1,238,324
1,265,401
1,304,429
1,215,145
1,128,295
1,308,284
1,300,205
1,213,412
1,190,148
1,165,297
1,194,082
1,208,999
1,156,988
1,169,400
1,213,373
1,220,323
1,244,138
1,303,210
1,300,980
1,343,181
1,415,990
1,506,643
1,474,454
1,521,938
1,629,895
1,705,488
1,695,904
1,822,301
2,151,765
2,351,763
2,328,457
2,868,869
2,885,839
3,113,297
2,898,775
2,922,875
3,024,068
3,215,376
3,300,900
3,942,159
4,948,271
5,140,009
4,989,153
5,113,070
5,402,263
5,441,249
5,548,187
5,739,001
6,338,173
6,735,140
6,795,971
6,569,594
6,891,613
7,232,479
6,981,403
7,106,482
7,434,931
7,825,548
7,663,342
7,987,575
8,122,108
8,119,919
8,334,111
8,337,323
8,892,919
9,034,708
9,029,349
9,091,274
9,431,958
9,244,435
9,025,729
9,290,530
9,565,383
9,565,3839,290,5309,025,7299,244,4359,431,9589,091,2749,029,3499,034,7088,892,9198,337,3238,334,1118,119,9198,122,1087,987,5757,663,3427,825,5487,434,9317,106,4826,981,4037,232,4796,891,6136,569,5946,795,9716,735,1406,338,1735,739,0015,548,1875,441,2495,402,2635,113,0704,989,1535,140,0094,948,2713,942,1593,300,9003,215,3763,024,0682,922,8752,898,7753,113,2972,885,8392,868,8692,328,4572,351,7632,151,7651,822,3011,695,9041,705,4881,629,8951,521,9381,474,4541,506,6431,415,9901,343,1811,300,9801,303,2101,244,1381,220,3231,213,3731,169,4001,156,9881,208,9991,194,0821,165,2971,190,1481,213,4121,300,2051,308,2841,128,2951,215,1451,304,4291,265,4011,238,3241,376,0851,127,7211,032,4611,171,9471,081,447984,933970,314946,711951,483852,859835,482763,285780,336769,950778,291763,983755,246798,796
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,995,861
3,539,740
4,201,018
4,778,691
4,500,777
4,550,937
4,801,861
5,189,942
5,042,807
5,354,746
5,563,662
5,496,263
5,669,825
5,630,051
6,180,248
6,319,785
6,305,993
6,399,947
6,766,375
6,572,032
6,407,462
6,698,254
7,031,045
7,031,0456,698,2546,407,4626,572,0326,766,3756,399,9476,305,9936,319,7856,180,2485,630,0515,669,8255,496,2635,563,6625,354,7465,042,8075,189,9424,801,8614,550,9374,500,7774,778,6914,201,0183,539,7403,995,86100000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
912,864
515,929
1,200,561
541,855
690,675
1,133,504
1,271,142
940,435
971,404
935,504
1,473,146
993,906
1,089,847
898,074
1,574,252
1,062,815
1,005,574
1,257,280
1,658,392
1,281,209
1,238,593
1,125,189
1,493,010
1,493,0101,125,1891,238,5931,281,2091,658,3921,257,2801,005,5741,062,8151,574,252898,0741,089,847993,9061,473,146935,504971,404940,4351,271,1421,133,504690,675541,8551,200,561515,929912,86400000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
355,000
0
106,000
1,077,945
785,900
336,100
210,900
787,900
585,583
643,583
334,760
469,084
406,461
471,461
160,502
388,000
340,000
220,000
319,402
0
80,000
481,398
603,795
603,795481,39880,0000319,402220,000340,000388,000160,502471,461406,461469,084334,760643,583585,583787,900210,900336,100785,9001,077,945106,0000355,00000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
150,638
155,174
133,343
165,405
185,250
192,170
175,230
199,719
198,970
236,288
277,880
365,090
361,073
409,683
375,487
425,573
494,720
693,636
444,161
535,723
488,286
471,035
381,335
383,468
391,674
379,038
346,943
336,653
360,867
360,827
324,866
344,961
354,128
377,506
319,177
367,426
335,800
351,446
383,640
394,659
392,562
457,580
437,234
463,335
502,367
555,209
460,262
605,729
580,483
672,259
542,810
765,759
721,224
725,887
613,933
809,501
805,975
925,242
772,644
884,554
854,253
871,280
937,219
1,087,175
1,153,647
1,375,953
1,316,265
1,508,501
1,475,129
1,459,617
1,513,947
1,336,886
1,291,039
1,314,609
1,719,966
1,673,438
1,755,540
1,876,463
1,803,412
1,881,626
2,111,104
2,129,202
2,085,544
2,659,985
2,974,503
2,970,367
2,436,867
2,859,736
3,133,755
2,809,115
2,550,998
2,550,9982,809,1153,133,7552,859,7362,436,8672,970,3672,974,5032,659,9852,085,5442,129,2022,111,1041,881,6261,803,4121,876,4631,755,5401,673,4381,719,9661,314,6091,291,0391,336,8861,513,9471,459,6171,475,1291,508,5011,316,2651,375,9531,153,6471,087,175937,219871,280854,253884,554772,644925,242805,975809,501613,933725,887721,224765,759542,810672,259580,483605,729460,262555,209502,367463,335437,234457,580392,562394,659383,640351,446335,800367,426319,177377,506354,128344,961324,866360,827360,867336,653346,943379,038391,674383,468381,335471,035488,286535,723444,161693,636494,720425,573375,487409,683361,073365,090277,880236,288198,970199,719175,230192,170185,250165,405133,343155,174150,638
       Other Current Assets 
7,946
6,753
8,291
11,176
20,544
44,938
51,567
64,835
53,305
49,358
13,418
9,203
18,468
27,993
57,830
75,749
79,524
82,195
82,584
44,150
53,817
31,641
81,982
77,350
80,145
40,429
44,263
22,101
34,624
20,353
25,309
19,566
25,964
41,267
24,179
21,359
43,804
53,929
64,878
113,484
143,884
82,673
75,231
83,417
95,762
111,752
138,416
146,168
182,113
648,947
616,503
112,442
67,256
466,388
124,752
205,081
101,736
284,499
133,601
1,017,017
137,927
952,510
144,284
311,664
124,544
628,390
145,061
646,780
178,183
467,647
206,536
57,227
51,357
48,485
155,087
225,075
144,216
275,872
234,763
324,471
265,760
265,879
465,277
257,290
151,630
168,626
45,878
39,205
162,187
87,463
78,916
78,91687,463162,18739,20545,878168,626151,630257,290465,277265,879265,760324,471234,763275,872144,216225,075155,08748,48551,35757,227206,536467,647178,183646,780145,061628,390124,544311,664144,284952,510137,9271,017,017133,601284,499101,736205,081124,752466,38867,256112,442616,503648,947182,113146,168138,416111,75295,76283,41775,23182,673143,884113,48464,87853,92943,80421,35924,17941,26725,96419,56625,30920,35334,62422,10144,26340,42980,14577,35081,98231,64153,81744,15082,58482,19579,52475,74957,83027,99318,4689,20313,41849,35853,30564,83551,56744,93820,54411,1768,2916,7537,946
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,453,787
2,480,626
2,555,545
2,633,070
2,635,606
2,620,535
2,632,829
2,558,447
2,623,656
2,664,286
2,707,272
2,712,671
2,714,922
2,723,356
2,691,327
2,665,583
2,672,402
2,618,267
2,592,276
2,534,339
2,534,3392,592,2762,618,2672,672,4022,665,5832,691,3272,723,3562,714,9222,712,6712,707,2722,664,2862,623,6562,558,4472,632,8292,620,5352,635,6062,633,0702,555,5452,480,6262,453,78700000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
123,685
133,075
138,102
138,270
125,298
136,326
150,321
154,353
161,817
181,848
218,528
218,949
221,194
222,092
229,658
237,149
244,597
248,876
281,689
279,348
285,126
279,299
283,514
350,885
361,455
338,640
350,047
329,027
338,019
318,858
327,540
309,469
304,339
299,836
307,924
284,325
300,529
277,772
298,878
279,000
303,174
287,267
330,033
308,654
323,480
310,166
460,696
322,507
477,739
352,807
645,806
535,489
487,497
488,922
486,698
499,959
508,734
724,970
762,371
829,866
794,791
806,874
815,179
839,890
880,153
944,961
987,298
1,018,886
1,060,705
1,089,899
1,222,638
1,261,594
1,284,023
1,353,991
1,353,521
1,341,952
1,340,512
1,360,072
1,328,402
1,392,776
1,382,885
1,397,169
1,360,523
1,367,622
1,346,488
1,321,742
1,291,415
1,298,584
1,273,159
1,259,122
1,248,690
1,248,6901,259,1221,273,1591,298,5841,291,4151,321,7421,346,4881,367,6221,360,5231,397,1691,382,8851,392,7761,328,4021,360,0721,340,5121,341,9521,353,5211,353,9911,284,0231,261,5941,222,6381,089,8991,060,7051,018,886987,298944,961880,153839,890815,179806,874794,791829,866762,371724,970508,734499,959486,698488,922487,497535,489645,806352,807477,739322,507460,696310,166323,480308,654330,033287,267303,174279,000298,878277,772300,529284,325307,924299,836304,339309,469327,540318,858338,019329,027350,047338,640361,455350,885283,514279,299285,126279,348281,689248,876244,597237,149229,658222,092221,194218,949218,528181,848161,817154,353150,321136,326125,298138,270138,102133,075123,685
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,043
68,043
68,043
68,043
68,043
68,043
69,678
69,678
69,678
69,678
69,678
73,827
73,827
73,827
85,216
83,581
83,581
94,867
94,867
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,727
91,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72791,72794,86794,86783,58183,58185,21673,82773,82773,82769,67869,67869,67869,67869,67868,04368,04368,04368,04368,04368,043000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
864,872
1,051,652
573,904
284,457
277,940
277,697
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000277,697277,940284,457573,9041,051,652864,87200000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
17,380
7,103
6,682
6,406
5,705
5,244
5,005
4,749
4,495
4,636
4,647
4,634
6,228
4,125
5,403
5,356
3,532
5,237
13,312
15,693
12,727
15,093
11,977
49,372
11,350
79,663
10,563
96,095
10,089
97,981
4,528
100,258
4,565
103,698
4,353
110,337
4,351
115,434
4,247
120,936
4,518
127,543
5,835
128,754
5,112
135,782
4,740
263,920
4,279
284,121
4,564
222,587
282,738
281,697
262,453
342,354
339,725
371,863
308,503
305,916
347,700
345,271
430,631
425,724
456,422
510,151
508,636
500,674
423,063
415,047
407,785
602,644
367,709
609,744
627,637
635,910
609,926
609,786
570,753
577,629
601,607
610,933
608,763
598,264
564,814
564,620
529,997
527,269
526,353
531,976
525,493
525,493531,976526,353527,269529,997564,620564,814598,264608,763610,933601,607577,629570,753609,786609,926635,910627,637609,744367,709602,644407,785415,047423,063500,674508,636510,151456,422425,724430,631345,271347,700305,916308,503371,863339,725342,354262,453281,697282,738222,5874,564284,1214,279263,9204,740135,7825,112128,7545,835127,5434,518120,9364,247115,4344,351110,3374,353103,6984,565100,2584,52897,98110,08996,09510,56379,66311,35049,37211,97715,09312,72715,69313,3125,2373,5325,3565,4034,1256,2284,6344,6474,6364,4954,7495,0055,2445,7056,4066,6827,10317,380
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,751
30,411
29,589
37,967
39,925
45,118
1,399,298
1,363,397
34,418
32,824
55,178
63,019
70,792
71,881
84,000
136,081
140,453
98,789
62,101
41,441
41,44162,10198,789140,453136,08184,00071,88170,79263,01955,17832,82434,4181,363,3971,399,29845,11839,92537,96729,58930,41132,75100000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
241,154
187,064
204,242
207,031
184,186
196,330
192,113
248,601
246,918
319,057
286,757
292,860
311,636
394,412
448,749
288,715
381,088
598,009
650,309
671,329
721,684
628,781
544,436
710,598
680,607
601,747
554,983
524,511
538,657
548,734
486,485
492,349
519,684
503,746
505,789
552,725
543,665
553,259
595,838
666,532
642,196
651,456
712,372
752,773
755,575
834,164
1,095,060
1,250,877
1,241,787
1,057,483
1,006,656
1,176,008
981,918
945,454
974,400
1,066,452
1,010,405
1,582,509
1,612,414
1,717,834
1,583,538
1,606,925
1,790,255
1,733,307
1,838,167
2,018,160
2,564,472
2,875,752
2,972,822
2,689,612
2,943,113
3,179,903
2,867,127
2,888,395
3,100,786
3,387,206
3,298,146
3,492,335
3,519,444
3,314,379
3,567,504
3,469,247
3,952,604
3,976,923
4,060,566
3,958,933
4,289,436
3,975,068
3,780,304
3,881,262
4,088,814
4,088,8143,881,2623,780,3043,975,0684,289,4363,958,9334,060,5663,976,9233,952,6043,469,2473,567,5043,314,3793,519,4443,492,3353,298,1463,387,2063,100,7862,888,3952,867,1273,179,9032,943,1132,689,6122,972,8222,875,7522,564,4722,018,1601,838,1671,733,3071,790,2551,606,9251,583,5381,717,8341,612,4141,582,5091,010,4051,066,452974,400945,454981,9181,176,0081,006,6561,057,4831,241,7871,250,8771,095,060834,164755,575752,773712,372651,456642,196666,532595,838553,259543,665552,725505,789503,746519,684492,349486,485548,734538,657524,511554,983601,747680,607710,598544,436628,781721,684671,329650,309598,009381,088288,715448,749394,412311,636292,860286,757319,057246,918248,601192,113196,330184,186207,031204,242187,064241,154
   > Total Current Liabilities 
219,237
168,733
175,489
176,860
157,052
170,360
179,599
237,188
219,845
305,218
279,080
286,283
306,129
392,044
446,597
287,203
368,335
530,261
580,715
601,735
652,130
559,235
485,855
645,824
615,809
547,421
554,483
524,011
538,657
514,734
472,485
478,349
485,684
469,746
471,630
518,567
509,507
519,101
575,753
646,447
642,111
641,371
693,798
734,199
737,000
815,590
1,050,121
1,205,939
1,196,838
1,031,503
973,133
1,117,486
923,396
882,632
908,779
1,001,257
945,059
1,169,450
1,163,233
1,269,330
1,133,905
1,156,372
1,352,200
1,295,857
1,390,876
1,516,212
2,037,497
2,215,626
2,226,431
2,243,960
2,468,137
2,704,741
2,530,510
2,541,946
2,777,699
3,053,604
2,928,117
3,117,076
3,126,721
2,888,771
3,147,471
3,051,838
3,485,207
3,452,702
3,630,589
3,534,869
3,888,866
3,569,617
3,423,951
3,451,364
3,644,259
3,644,2593,451,3643,423,9513,569,6173,888,8663,534,8693,630,5893,452,7023,485,2073,051,8383,147,4712,888,7713,126,7213,117,0762,928,1173,053,6042,777,6992,541,9462,530,5102,704,7412,468,1372,243,9602,226,4312,215,6262,037,4971,516,2121,390,8761,295,8571,352,2001,156,3721,133,9051,269,3301,163,2331,169,450945,0591,001,257908,779882,632923,3961,117,486973,1331,031,5031,196,8381,205,9391,050,121815,590737,000734,199693,798641,371642,111646,447575,753519,101509,507518,567471,630469,746485,684478,349472,485514,734538,657524,011554,483547,421615,809645,824485,855559,235652,130601,735580,715530,261368,335287,203446,597392,044306,129286,283279,080305,218219,845237,188179,599170,360157,052176,860175,489168,733219,237
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
600
720,025
616,025
608,931
501,331
550,016
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000550,016501,331608,931616,025720,02560010010000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
600
720,025
616,025
608,931
501,331
550,016
621,200
710,560
627,809
570,918
615,049
687,696
641,752
690,998
895,432
831,038
912,764
636,431
526,682
663,731
725,487
725,487663,731526,682636,431912,764831,038895,432690,998641,752687,696615,049570,918627,809710,560621,200550,016501,331608,931616,025720,02560010010000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
94,989
105,370
97,226
107,193
101,904
104,756
85,961
93,001
78,072
83,360
82,647
100,215
74,228
106,800
125,718
125,033
132,337
252,613
224,976
252,515
245,069
121,609
194,587
203,682
172,108
156,629
189,854
197,292
192,572
199,048
171,549
167,537
180,840
224,017
218,556
263,884
251,786
235,595
242,356
315,876
317,895
319,779
304,272
300,520
309,776
343,336
425,535
449,305
456,615
438,480
431,140
498,455
381,987
352,697
412,145
433,965
428,421
450,535
453,911
545,916
464,856
465,949
536,968
498,981
532,802
578,779
705,342
724,827
660,459
541,628
825,048
875,750
731,853
715,978
645,407
787,732
617,449
795,458
823,699
807,093
778,291
929,087
1,235,136
1,277,104
1,009,501
938,144
977,121
1,063,290
924,339
901,949
932,691
932,691901,949924,3391,063,290977,121938,1441,009,5011,277,1041,235,136929,087778,291807,093823,699795,458617,449787,732645,407715,978731,853875,750825,048541,628660,459724,827705,342578,779532,802498,981536,968465,949464,856545,916453,911450,535428,421433,965412,145352,697381,987498,455431,140438,480456,615449,305425,535343,336309,776300,520304,272319,779317,895315,876242,356235,595251,786263,884218,556224,017180,840167,537171,549199,048192,572197,292189,854156,629172,108203,682194,587121,609245,069252,515224,976252,613132,337125,033125,718106,80074,228100,21582,64783,36078,07293,00185,961104,756101,904107,19397,226105,37094,989
       Other Current Liabilities 
58,069
36,784
67,463
58,907
45,888
58,229
76,311
91,917
90,263
65,773
76,409
69,044
92,777
45,619
136,254
65,545
61,173
76,648
139,739
138,220
133,061
159,423
76,668
94,866
142,101
130,792
123,029
99,119
98,085
82,686
106,936
111,812
99,844
109,729
141,074
146,683
161,721
175,506
208,397
188,571
174,216
185,592
253,526
289,679
294,224
311,254
380,486
412,534
476,123
535,023
511,993
424,932
395,808
405,435
369,935
466,992
427,638
558,415
526,821
547,413
483,049
494,323
659,547
630,976
633,673
720,019
1,020,416
971,872
396,700
1,029,752
474,724
400
200
200
564,473
1,604,883
654,621
1,536,564
551,205
1,430,651
560,240
1,349,816
459,806
1,352,969
512,631
1,532,246
55,975
55,798
542,920
42,736
54,554
54,55442,736542,92055,79855,9751,532,246512,6311,352,969459,8061,349,816560,2401,430,651551,2051,536,564654,6211,604,883564,473200200400474,7241,029,752396,700971,8721,020,416720,019633,673630,976659,547494,323483,049547,413526,821558,415427,638466,992369,935405,435395,808424,932511,993535,023476,123412,534380,486311,254294,224289,679253,526185,592174,216188,571208,397175,506161,721146,683141,074109,72999,844111,812106,93682,68698,08599,119123,029130,792142,10194,86676,668159,423133,061138,220139,73976,64861,17365,545136,25445,61992,77769,04476,40965,77390,26391,91776,31158,22945,88858,90767,46336,78458,069
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
475,162
336,617
346,448
323,086
333,603
370,029
375,259
392,723
425,608
420,033
417,408
467,397
524,221
429,976
424,064
400,570
405,451
356,353
429,898
444,555
444,555429,898356,353405,451400,570424,064429,976524,221467,397417,408420,033425,608392,723375,259370,029333,603323,086346,448336,617475,16200000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-100
-100
-600
-720,025
-616,025
-608,931
-501,331
-550,016
0
0
0
33,442
26,388
26,133
50,474
58,455
76,329
69,721
44,769
46,599
36,812
37,238
44,238
44,23837,23836,81246,59944,76969,72176,32958,45550,47426,13326,38833,442000-550,016-501,331-608,931-616,025-720,025-600-100-10000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
254,600
105,200
115,000
66,700
66,700
99,800
2,232
0
1,050
0
976
56,667
56,667
57,309
62,075
77,580
72,967
72,744
72,602
74,854
74,85472,60272,74472,96777,58062,07557,30956,66756,66797601,05002,23299,80066,70066,700115,000105,200254,60000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
182,218
195,814
196,070
213,669
225,957
232,889
247,738
255,040
275,524
289,766
253,863
248,373
251,802
264,530
274,494
270,575
224,746
227,199
0
0
215,723
0
0
00215,72300227,199224,746270,575274,494264,530251,802248,373253,863289,766275,524255,040247,738232,889225,957213,669196,070195,814182,21800000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
511,949
529,846
518,856
528,782
542,712
547,784
530,835
544,156
562,452
576,113
600,155
615,473
612,198
635,868
667,865
685,777
689,156
719,767
518,145
522,827
523,748
525,664
524,487
540,437
549,680
550,970
574,509
579,629
592,224
596,376
606,568
612,095
626,518
647,458
665,788
677,943
680,567
709,702
735,241
752,430
742,015
776,244
818,178
851,138
835,192
877,545
938,680
980,909
961,203
1,687,375
1,757,991
1,811,898
1,786,550
1,841,761
1,924,254
1,941,578
2,081,724
2,136,354
3,311,761
3,397,521
3,380,883
3,480,777
3,557,533
3,652,850
3,636,536
3,616,823
3,665,883
3,750,654
3,695,023
3,749,496
3,820,539
3,916,625
3,981,037
4,096,449
4,196,201
4,297,252
4,220,427
4,347,739
4,450,662
4,645,933
4,609,586
4,712,391
4,783,336
4,898,361
4,812,400
4,970,730
4,983,023
5,113,946
5,086,031
5,246,813
5,297,444
5,297,4445,246,8135,086,0315,113,9464,983,0234,970,7304,812,4004,898,3614,783,3364,712,3914,609,5864,645,9334,450,6624,347,7394,220,4274,297,2524,196,2014,096,4493,981,0373,916,6253,820,5393,749,4963,695,0233,750,6543,665,8833,616,8233,636,5363,652,8503,557,5333,480,7773,380,8833,397,5213,311,7612,136,3542,081,7241,941,5781,924,2541,841,7611,786,5501,811,8981,757,9911,687,375961,203980,909938,680877,545835,192851,138818,178776,244742,015752,430735,241709,702680,567677,943665,788647,458626,518612,095606,568596,376592,224579,629574,509550,970549,680540,437524,487525,664523,748522,827518,145719,767689,156685,777667,865635,868612,198615,473600,155576,113562,452544,156530,835547,784542,712528,782518,856529,846511,949
   Common Stock
98,180
98,180
98,180
98,180
98,180
98,180
98,180
98,180
98,180
98,180
98,180
98,180
98,180
98,180
157,088
157,088
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
314,176
341,130
341,130
341,130
341,130
341,130
341,130
341,130
341,130
341,130
394,344
394,344
788,689
788,689
788,689
788,689
788,689
788,689
788,689
786,198
786,198
786,198
762,392
762,392
761,218
761,218
760,948
760,948
760,948
758,388
758,256
758,256
758,256
758,256
758,256
758,256
758,256
758,256
0
0
758,128
0
0
00758,12800758,256758,256758,256758,256758,256758,256758,256758,256758,388760,948760,948760,948761,218761,218762,392762,392786,198786,198786,198788,689788,689788,689788,689788,689788,689788,689394,344394,344341,130341,130341,130341,130341,130341,130341,130341,130341,130314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176314,176157,088157,08898,18098,18098,18098,18098,18098,18098,18098,18098,18098,18098,18098,18098,18098,180
   Retained Earnings 
92
17,768
2
9,927
23,853
28,925
4,204
17,525
35,816
49,477
37,101
76,965
73,565
97,095
91,011
108,923
44,413
75,025
0
0
0
0
0
0
0
0
15,023
20,648
32,739
36,890
47,141
52,668
67,092
88,031
103,200
115,355
117,980
147,115
168,007
185,197
174,781
209,010
241,867
274,261
258,880
301,233
347,396
390,363
369,746
415,004
466,819
614,806
589,458
644,668
733,740
751,219
891,501
996,902
1,106,493
1,191,873
1,193,180
1,275,230
1,352,068
1,446,510
1,425,622
1,490,360
1,540,201
1,622,455
1,720,799
1,805,856
1,875,737
1,744,271
1,800,573
1,925,052
2,254,729
2,346,558
2,328,363
2,454,758
2,560,611
2,755,506
2,718,615
2,820,409
2,894,108
3,008,575
2,904,001
3,060,081
2,715,192
2,846,219
3,172,651
2,979,921
3,017,324
3,017,3242,979,9213,172,6512,846,2192,715,1923,060,0812,904,0013,008,5752,894,1082,820,4092,718,6152,755,5062,560,6112,454,7582,328,3632,346,5582,254,7291,925,0521,800,5731,744,2711,875,7371,805,8561,720,7991,622,4551,540,2011,490,3601,425,6221,446,5101,352,0681,275,2301,193,1801,191,8731,106,493996,902891,501751,219733,740644,668589,458614,806466,819415,004369,746390,363347,396301,233258,880274,261241,867209,010174,781185,197168,007147,115117,980115,355103,20088,03167,09252,66847,14136,89032,73920,64815,0230000000075,02544,413108,92391,01197,09573,56576,96537,10149,47735,81617,5254,20428,92523,8539,927217,76892
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-260,424-229,362-59,812-86,864-86,8640000-18,019000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,231
6,441
1,730
1,809
1,699
1,716
-9
842
1,445
1,360
-4,932
-4,556
-5,474
-5,924
-11,502
-13,137
-1,021
569
0
0
6,915
0
0
006,91500569-1,021-13,137-11,502-5,924-5,474-4,556-4,9321,3601,445842-91,7161,6991,8091,7306,4416,23100000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,703,121
Cost of Revenue-4,250,581
Gross Profit3,452,5413,452,541
 
Operating Income (+$)
Gross Profit3,452,541
Operating Expense-7,024,880
Operating Income678,241-3,572,339
 
Operating Expense (+$)
Research Development71,263
Selling General Administrative2,509,429
Selling And Marketing Expenses0
Operating Expense7,024,8802,580,692
 
Net Interest Income (+$)
Interest Income12,048
Interest Expense-21,590
Other Finance Cost-2,791
Net Interest Income-12,333
 
Pretax Income (+$)
Operating Income678,241
Net Interest Income-12,333
Other Non-Operating Income Expenses0
Income Before Tax (EBT)563,620678,241
EBIT - interestExpense = -21,590
444,680
466,270
Interest Expense21,590
Earnings Before Interest and Taxes (EBIT)0585,210
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax563,620
Tax Provision-109,477
Net Income From Continuing Ops454,143454,143
Net Income444,680
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net012,333
 

Technical Analysis of Kpc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kpc. The general trend of Kpc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kpc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of KPC Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 22.38 < 22.38 < 22.50.

The bearish price targets are: 20.60 > 18.73 > 17.66.

Tweet this
KPC Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of KPC Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

KPC Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of KPC Pharmaceuticals Inc. The current macd is 0.25022251.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kpc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Kpc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Kpc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
KPC Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartKPC Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of KPC Pharmaceuticals Inc. The current adx is 27.35.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Kpc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
KPC Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of KPC Pharmaceuticals Inc. The current sar is 22.26.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
KPC Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of KPC Pharmaceuticals Inc. The current rsi is 54.50. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
KPC Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartKPC Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of KPC Pharmaceuticals Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kpc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
KPC Pharmaceuticals Inc Daily Stochastic Oscillator ChartKPC Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of KPC Pharmaceuticals Inc. The current cci is 12.17.

KPC Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartKPC Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of KPC Pharmaceuticals Inc. The current cmo is 7.90235125.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
KPC Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartKPC Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of KPC Pharmaceuticals Inc. The current willr is -26.62116041.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Kpc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
KPC Pharmaceuticals Inc Daily Williams %R ChartKPC Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of KPC Pharmaceuticals Inc.

KPC Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of KPC Pharmaceuticals Inc. The current atr is 0.82473924.

KPC Pharmaceuticals Inc Daily Average True Range (ATR) ChartKPC Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of KPC Pharmaceuticals Inc. The current obv is 257,463,568.

KPC Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartKPC Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of KPC Pharmaceuticals Inc. The current mfi is 42.39.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
KPC Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartKPC Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for KPC Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

KPC Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of KPC Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.500
Ma 20Greater thanMa 5021.412
Ma 50Greater thanMa 10020.631
Ma 100Greater thanMa 20020.365
OpenGreater thanClose21.600
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kpc with someone you think should read this too:
  • Are you bullish or bearish on Kpc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kpc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about KPC Pharmaceuticals Inc

I send you an email if I find something interesting about KPC Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about KPC Pharmaceuticals Inc.

Receive notifications about KPC Pharmaceuticals Inc in your mailbox!